%0 Journal Article
%T Cost-effectiveness of hip fracture prevention
%J Epidemiologia e Prevenzione
%D 1998
%A Visentin, P.
%A Ciravegna, R.
%A Corcelli, F.
%A Fabris, F.
%V 22
%N 1
%P 44-48
%X We estimated the Cost Per Avoided Hip Fracture (CPAHF, millions Lira) by osteoporosis treatment, on the basis of a review on randomized controlled trials. Prevention with vitamin D3 in institutionalized elderly women is cost-neutral (CPAHF = -4; 95% CI = -9, +5). Prevention with alendronate in non-institutionalized women screened on bone mineral density generates doubts (CPAHF = 275; 95% CI = 146, 19.426). The cost-effectiveness analyses can strengthen or weaken conclusions of the clinical trials and discourage the use of economically unsustainable preventive treatments whose efficacy is unproven.<p /><p>Language: it</p>
%G it
%I Cooperativa Epidemiologia E Prevenzione
%@ 1120-9763
%U http://dx.doi.org/